Tyson Foods Announces To Drop ‘No Antibiotics Ever’ Label On Chicken Products
According to a spokesperson from Tyson Foods, the company will be reintroducing certain antibiotics into its chicken supply chain and discontinuing the use of the ‘no antibiotics ever’ tagline on Tyson-branded chicken products. These antibiotics, as stated by the company, are not deemed medically significant for human health.
Specifically, it has been reported by The Wall Street Journal, citing insider sources, that Tyson plans to incorporate ionophores into the diets of some of its chickens. This change will apply to all fresh, frozen, and ready-made products bearing the Tyson brand.
Ionophores are primarily utilized in poultry farming to manage coccidiosis, promote intestinal health, and support overall well-being of the birds. It is worth noting that these compounds are not classified as medically important by the World Health Organization for treating human ailments.
Regarding this transition, a spokesperson from Tyson Foods stated, “In line with the latest scientific knowledge, Tyson branded products are undergoing a transition to No Antibiotics Important to Human Medicine (NAIHM), which is anticipated to be finalized by the conclusion of the current calendar year.”
In 2017, the US meatpacking company made a transition for its retail line of chicken products under its own brand, ensuring that the birds were raised without the use of any antibiotics.
However, in May of this year, the maker of Jimmy Dean sausages revised its full-year revenue projection, citing price increases and persistently high inflation as factors dampening consumer spending on its products.
The company now anticipates sales for fiscal year 2023 to range between $53 billion (€48 billion) and $54 billion (€49 billion), as compared to its previous forecast of $55 billion (€50 billion) to $57 billion (€51.6 billion).
